Dyne Therapeutics, Inc. (20240252666). MUSCLE TARGETING COMPLEXES AND FORMULATIONS FOR TREATING MYOTONIC DYSTROPHY
MUSCLE TARGETING COMPLEXES AND FORMULATIONS FOR TREATING MYOTONIC DYSTROPHY
Organization Name
Inventor(s)
Scott Hilderbrand of Waltham MA US
Timothy Weeden of Waltham MA US
Stefano Zanotti of Waltham MA US
Romesh R. Subramanian of Framingham MA US
Mohammed T. Qatanani of Waltham MA US
Cody A, Desjardins of Waltham MA US
MUSCLE TARGETING COMPLEXES AND FORMULATIONS FOR TREATING MYOTONIC DYSTROPHY
This abstract first appeared for US patent application 20240252666 titled 'MUSCLE TARGETING COMPLEXES AND FORMULATIONS FOR TREATING MYOTONIC DYSTROPHY
Original Abstract Submitted
aspects of the disclosure relate to complexes and other aspects relate to formulations (e.g., aqueous, lyophilized forms) comprising such complexes comprising an oligonucleotide (e.g., useful for targeting dmpk) covalently linked to an antibody (e.g., anti-tfr1 antibody).
Categories:
- Dyne Therapeutics, Inc.
- Scott Hilderbrand of Waltham MA US
- Timothy Weeden of Waltham MA US
- John Najim of Waltham MA US
- Stefano Zanotti of Waltham MA US
- Romesh R. Subramanian of Framingham MA US
- Mohammed T. Qatanani of Waltham MA US
- Cody A, Desjardins of Waltham MA US
- Kim Tang of Waltham MA US
- Brendan Quinn of Boston MA US
- A61K47/68
- A61K47/54
- A61P21/00
- CPC A61K47/6807